BLCO Stock Analysis

Bausch + Lomb Corp
HEALTHCARE MEDICAL INSTRUMENTS & SUPPLIES

Back to Winners View Yahoo Finance Chart Buy on the Dip
Strong Caution Mixed Weak Unavailable
StockValueFinder Grade
F
44.56 / 100
Weak
Confidence: Very High (97.0%) Coverage: 97.0%
Business Quality 14.8
Financial Strength 49.8
Earnings & Growth 42.5
Valuation 58.1
Market Strength 72.0
The grade combines Business Quality, Financial Strength, Earnings & Growth, Valuation, and Market Strength. Rating and Trend remain separate signals.
Rating AVOID
Avoid
The screening rules are warning against this setup.
Rating is the simple decision label from the screening rules.
Trend STRONG BUY TREND
Bullish
The available trend signal is constructive.
Trend shows whether price action is helping or hurting the setup.
P/E Ratio 34.94
Rich
Investors are paying for meaningful future growth.
P/E shows how much investors pay for each dollar of earnings.
ROIC -3.05%
Poor
Negative ROIC suggests capital is not being used profitably.
ROIC measures how efficiently capital turns into profit.
Debt Payback -76.41 yrs
Unavailable
Debt payback is unavailable or not meaningful.
Debt payback estimates how quickly debt could be covered.
Interest Coverage 0.44x
Weak
Low coverage can make debt more risky.
Interest coverage shows how easily earnings cover interest costs.
Price $17.47
Market Price
Price alone is not a buy or sell signal.
Price should be judged with valuation, quality, and trend.
Last updated: 2026-10-25 20:18:24

Performance Overview

Trailing adjusted-close returns as of 2026-06-29. Benchmark is SPY.

YTD Return

BLCO -2.63%
SPY +9.24%

1-Year Return

BLCO +34.11%
SPY +21.84%

3-Year Return

BLCO -13.30%
SPY +75.56%

5-Year Return

BLCO N/A
SPY +85.41%

Returns are calculated from adjusted close prices and may differ from broker or research-site totals depending on data source, dividend handling, benchmark choice, and latest available trading date.

Legacy Screening Checks

This page uses cached SQL data from the latest StockValueFinder scan, so it loads fast without hitting Alpha Vantage on every page view.

33%
EPS Strength
FAIL

Looks for positive and improving earnings per share.

ROIC 10%+
FAIL

Looks for strong return on invested capital.

Interest Coverage 6+
FAIL

Checks whether operating income comfortably covers interest expense.

Debt Payback ≤ 3 Years
PASS

Checks whether free cash flow could pay down long-term debt quickly.

P/E 15 or Less
FAIL

Checks whether valuation is reasonable under the current rule set.

Moving Average Trend
STRONG BUY TREND

Uses 20-day, 50-day, and 200-day moving averages for entry timing context.

A high StockValueFinder score is a research signal, not a guarantee. Strong companies can still fall during recessions, sector downturns, valuation resets, or company-specific events. Always review the business, risks, SEC filings, valuation, and your personal investment goals before buying.

Cached Technical Data

Moving average values from the latest stored scan.

20-Day MA16.90
50-Day MA17.14
200-Day MA16.63
MA Score5

Latest Published Stock Research

Research generated: October 24, 2026

BLCO Stock Analysis: Why Bausch + Lomb Corp Scored 33% in Stock Value Finder

Bausch + Lomb Corp (BLCO) StockValueFinder Review

Bausch + Lomb Corp is a healthcare company operating in the medical instruments and supplies industry. This article provides an educational review of BLCO using the metrics from StockValueFinder, a tool designed to help investors evaluate stocks based on financial health indicators.

Why the StockValueFinder Score Matters StockValueFinder evaluates companies across various financial metrics to provide a comprehensive score that reflects their overall financial health. For Bausch + Lomb Corp (BLCO), the score is 33%, which falls below the threshold often considered indicative of strong financial performance. This low score, combined with the AVOID rating, suggests caution when considering investment in BLCO.

EPS Strength and Consistency Earnings Per Share (EPS) measures a company's profitability per share. StockValueFinder evaluates whether a stock has consistent positive EPS over time to ensure earnings stability. For Bausch + Lomb Corp, the EPS test was not passed. While specific historical EPS values are not provided, this indicates that BLCO may have inconsistent or negative EPS figures, which can be a red flag for financial health and future profitability.

ROIC and Capital Efficiency Return on Invested Capital (ROIC) measures how efficiently a company uses its capital to generate returns. A higher ROIC is generally preferred as it suggests better use of resources. Bausch + Lomb Corp's ROIC is -3.05%, which is significantly negative, failing the StockValueFinder test for this metric. In contrast, an ideal ROIC would be 10% or higher, indicating that BLCO is not effectively utilizing its capital compared to companies with a positive and robust ROIC.

Interest Coverage and Financial Safety Interest coverage measures a company's ability to meet interest payments on outstanding debt. A ratio of at least 6 is generally considered healthy by StockValueFinder. Bausch + Lomb Corp did not pass the interest coverage test, suggesting potential financial instability due to high levels of debt or insufficient earnings to cover interest expenses.

Debt Payback and Balance Sheet Discipline Debt payback years indicate how long it would take a company to repay its total debt using current net income. A shorter period is preferable as it indicates better balance sheet health. Bausch + Lomb Corp's debt payback year of -76.41 years, while unusual (as negative values typically suggest no debt), passes the test because it implies zero debt obligations. However, this could be misleading if there are off-balance-sheet liabilities or other financial risks not captured in the data.

P/E Ratio and Valuation Discipline The Price-to-Earnings (P/E) ratio compares a stock's market value to its earnings per share. A lower P/E is usually preferred as it suggests better valuation discipline, with StockValueFinder typically looking for ratios of 15 or less. Bausch + Lomb Corp’s P/E ratio stands at 34.94, failing the test and indicating that BLCO may be overvalued relative to its earnings.

Moving Average Trend and Entry Timing The moving average trend signal provides insight into short-term price trends. For Bausch + Lomb Corp, the STRONG BUY TREND indicates a favorable near-term outlook based on technical analysis. However, this does not guarantee future gains; it merely suggests that current market conditions favor buying.

Overall Financial Strengths and Weaknesses

Bausch + Lomb Corp’s financial metrics reveal several areas of concern

Negative ROIC (-3.05%) indicates poor capital efficiency. - Unfavorable P/E ratio (34.94) raises questions about valuation. - Lack of consistent positive EPS suggests earnings instability.

However, the low debt payback years and strong moving average trend offer some positives but do not outweigh the significant financial risks highlighted by other metrics.

Risks and Limitations Investing in Bausch + Lomb Corp based on current data poses considerable risk due to poor capital efficiency, high valuation relative to earnings, and potential instability from interest coverage. These factors suggest that BLCO might be a speculative investment rather than a stable holding for conservative investors.

Educational Conclusion Understanding financial metrics like EPS consistency, ROIC, interest coverage, debt payback years, P/E ratios, and moving average trends is crucial for evaluating stock performance. For Bausch + Lomb Corp (BLCO), the StockValueFinder score of 33% with an AVOID rating highlights significant risks that may outweigh potential rewards.

This article is for research and educational purposes only. It is not personal financial advice, investment advice, or a recommendation to buy or sell any security.


Research links: Yahoo Finance | Seeking Alpha | Finviz | SEC Filings

Research Attribution
Max Qwen II

Specializing in monetary economics, market incentives, and investment risk.

30-Day Trendline Analysis

Optional intraday chart with rising support, falling resistance, and multi-timeframe views.

Load detailed price structure only when needed. Downloads roughly 30 days of 5-minute candles, identifies swing points, then calculates validated support and resistance lines.
Scroll to Top